Literature DB >> 11055653

Recurrence of urinary tract infections in adult patients with community-acquired pyelonephritis caused by E. coli: a 1-year follow-up.

U M Kärkkäinen1, R Ikäheimo, M L Katila, A Siitonen.   

Abstract

In a prospective study, 42 women were followed for recurrence of urinary tract infections (UTIs) for 1 y after an index episode of community-acquired pyelonephritis caused by Escherichia coli. Altogether, 26 repeat episodes were detected. Of these, 20 occurred at least 1 month after the index episode and were regarded as recurrences. In all, 40%, (17 of 42) of the women had recurrences. An earlier history of UTI increased the risk of recurrence: 52%, of the 29 women with previous UTI had at least 1 recurrence, compared with 15%, of the 13 patients without previous UTI. E. coli caused the majority (73%) of the recurrences. Genotype comparisons by RAPD-PCR analysis between E. coli isolates from a patient showed that 75%. of the original and recurrent strains were genetically non-identical. Of the 54 E. coli strains, 42 were carrying genes coding for G adhesins of P fimbriae: 40 isolates carried class II, I class III and 1 carried both class II and III G adhesin genes. Each of the virulence-associated factors (genes for G adhesins, MRHA, haemolysin, type 1C fimbriae, and O and K antigens) was evenly distributed among E. coli isolates of index episodes, independent of the recurrences. The index isolates, however, had more virulence-associated factors than did the isolates from the recurrences which were mainly due to lower UTIs.

Entities:  

Mesh:

Year:  2000        PMID: 11055653     DOI: 10.1080/003655400458767

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  17 in total

1.  Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.

Authors:  Matthew G Blango; Matthew A Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

Review 2.  Covert operations of uropathogenic Escherichia coli within the urinary tract.

Authors:  Jean M Bower; Danelle S Eto; Matthew A Mulvey
Journal:  Traffic       Date:  2005-01       Impact factor: 6.215

Review 3.  [Recurrent urinary tract infections in women. Virulence of pathogens and host reaction].

Authors:  T Oelschlaeger; R Fünfstück
Journal:  Urologe A       Date:  2006-04       Impact factor: 0.639

4.  Subsequent infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in patients with prior infection or fecal colonization.

Authors:  Anna Lindblom; Nahid Karami; Tim Magnusson; Christina Åhrén
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-23       Impact factor: 3.267

Review 5.  Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy.

Authors:  Patricia Brown; Moran Ki; Betsy Foxman
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 6.  From physiology to pharmacy: developments in the pathogenesis and treatment of recurrent urinary tract infections.

Authors:  Jennifer A Silverman; Henry L Schreiber; Thomas M Hooton; Scott J Hultgren
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

7.  Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli.

Authors:  Joel D Schilling; Robin G Lorenz; Scott J Hultgren
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

8.  Similarity and divergence of phylogenies, antimicrobial susceptibilities, and virulence factor profiles of Escherichia coli isolates causing recurrent urinary tract infections that persist or result from reinfection.

Authors:  Yanping Luo; Yanning Ma; Qiang Zhao; Leili Wang; Ling Guo; Liyan Ye; Youjiang Zhang; Jiyong Yang
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

9.  Lipopolysaccharide Domains Modulate Urovirulence.

Authors:  Lizath M Aguiniga; Ryan E Yaggie; Anthony J Schaeffer; David J Klumpp
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

10.  Viable but nonculturable bacteria are present in mouse and human urine specimens.

Authors:  Marc Anderson; Daphne Bollinger; Ashley Hagler; Hadley Hartwell; Bryan Rivers; Kristie Ward; Todd R Steck
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.